Literature DB >> 31157361

Measuring Catastrophic Health Expenditures and its Inequality: Evidence from Iran's Health Transformation Program.

Vahid Yazdi-Feyzabadi1, Mohammad Hossein Mehrolhassani2, Ali Darvishi3,4.   

Abstract

One of the important goals of Iran's health transformation programme (HTP) is to improve financial protection for households against health expenditure. This study aimed to investigate the occurrence, intensity and inequality in distribution of catastrophic health expenditure (CHE) using the WHO and the World Bank (WB) methodologies with different thresholds in the years before and after HTP. We used data from seven annual national repeated cross-sectional surveys on households' income and expenditures from 2011 to 2017. The intensity to CHE was calculated using overshoot and mean positive overshoot (MPO) indices. Finally, the inequality in distribution of exposure to CHE was calculated using the concentration index (CI), and the dominance test of concentration curves was used to inference about the significant changes in inequality of the years before and after HTP. The exposure rate to CHE in the total population and at 40% threshold of the WHO methodology changed from 1.99% in 2011 to 3.46% in 2017. Additionally, at 20% threshold of the WB methodology, it was changed from 5.14% to 8.68%. Overshoot and MPO indices increased on average based on two methodologies in urban and rural areas during seven years. The CIs for all the years show a negative value in both methodologies, indicating that CHE occurrence is higher among the poor households. In 2017, at 40% threshold of the WHO, the numerical values of the CIs were -0.15 and -0.14 in urban and rural populations, respectively. These values were -0.07 and -0.05 for the 20% threshold of WB, respectively. Results of dominance test showed no significant change in inequality for the years after than before HTP with two exceptions for total and rural populations based on the WB methodology. Generally, HTP had no considerable success in financial protection, requiring a review in actions to support pro-poor adaptation strategies.
© The Author(s) 2019. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Catastrophic health expenditure; Iran’s health transformation programme; health inequalities; health policy

Mesh:

Year:  2019        PMID: 31157361     DOI: 10.1093/heapol/czz031

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  6 in total

1.  The Impact of Cancer Incidence on Catastrophic Health Expenditure in Iran with a Bayesian Spatio-Temporal Analysis.

Authors:  Nazanin Fekri; Mahboubeh Parsaeian; Abolghasem Pourreza; Ben Swallow; Aminreza Amini; Abbas Rahimi Foroushani
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

2.  What Policy Approaches Were Effective in Reducing Catastrophic Health Expenditure? A Systematic Review of Studies from Multiple Countries.

Authors:  HyunWoo Jung; Kwang-Soo Lee
Journal:  Appl Health Econ Health Policy       Date:  2022-03-14       Impact factor: 3.686

3.  Financial burden imposed on the insured patients for private treatment: Evidence from a state of Iran.

Authors:  Manal Etemadi; Mohammad Shiri; Elham Rostami; Mohammad Mohseni; Masumeh Seyedi
Journal:  J Educ Health Promot       Date:  2019-12-31

4.  The comparison of catastrophic health expenditure and its inequality between urban and rural households in China.

Authors:  Xian-Zhi Fu
Journal:  Health Econ Rev       Date:  2022-03-09

5.  Financial risk protection from out-of-pocket health spending in low- and middle-income countries: a scoping review of the literature.

Authors:  Taslima Rahman; Dominic Gasbarro; Khurshid Alam
Journal:  Health Res Policy Syst       Date:  2022-07-29

6.  What are the potential advantages and disadvantages of merging health insurance funds? A qualitative policy analysis from Iran.

Authors:  Mohammad Bazyar; Vahid Yazdi-Feyzabadi; Nouroddin Rahimi; Arash Rashidian
Journal:  BMC Public Health       Date:  2020-08-31       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.